These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning. Schenk D Nat Rev Neurosci; 2002 Oct; 3(10):824-8. PubMed ID: 12360327 [No Abstract] [Full Text] [Related]
11. Does oxybutynin alter plaques, amyloid beta peptides and behavior in a mouse model of Alzheimer's disease? Klausner AP; Sharma S; Fletcher S; Neff P; Yang SK; Son H; Tuttle JB; Steers WD J Urol; 2008 Mar; 179(3):1173-7. PubMed ID: 18206173 [TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research. Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974 [TBL] [Abstract][Full Text] [Related]
18. In vivo targeting of antibody fragments to the nervous system for Alzheimer's disease immunotherapy and molecular imaging of amyloid plaques. Poduslo JF; Ramakrishnan M; Holasek SS; Ramirez-Alvarado M; Kandimalla KK; Gilles EJ; Curran GL; Wengenack TM J Neurochem; 2007 Jul; 102(2):420-33. PubMed ID: 17596213 [TBL] [Abstract][Full Text] [Related]
19. Immunotherapy of Alzheimer's disease (AD): from murine models to anti-amyloid beta (Abeta) human monoclonal antibodies. Geylis V; Steinitz M Autoimmun Rev; 2006 Jan; 5(1):33-9. PubMed ID: 16338209 [TBL] [Abstract][Full Text] [Related]
20. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease. Busche MA; Eichhoff G; Adelsberger H; Abramowski D; Wiederhold KH; Haass C; Staufenbiel M; Konnerth A; Garaschuk O Science; 2008 Sep; 321(5896):1686-9. PubMed ID: 18802001 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]